Refreshing results…
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
UploadDouble PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
UploadNeratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
Uploadp95HER2–T cell bispecific antibody for breast cancer treatment
UploadMissing publications? Search for publications with a matching author name.